Outcome of total splenectomy with portosystemic shunt for massive splenomegaly and variceal bleeding in cystic fibrosis

Journal of Pediatric Surgery

Volumn 41, Issue 9, 2006, Pages 1561-1565

  Robberecht, Eddy ^a   Van Biervliet, Stephanie ^a   Vanrentergem, Katrien ^a   Kerremans, Ilse ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cystic fibrosis; Portal hypertension; Splenectomy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; PENICILLIN V; PNEUMOCOCCUS VACCINE;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; ARTICLE; CYSTIC FIBROSIS; ELECTIVE SURGERY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; HYPERSPLENISM; LONG TERM CARE; LUNG FUNCTION; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PUBERTY DISORDERS; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SCHOOL CHILD; SCLEROTHERAPY; SEPTICEMIA; SPLENECTOMY; SPLENOMEGALY; VACCINATION; WEIGHT GAIN;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; ESOPHAGEAL AND GASTRIC VARICES; FATAL OUTCOME; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; RECURRENCE; SPLENECTOMY; SPLENOMEGALY; SPLENORENAL SHUNT, SURGICAL; TREATMENT OUTCOME;

EID: 33748064336     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2006.05.006     Document Type: Article

References (27)

1. Sokol R.J., and Durie P.R. Recommendations for management of liver and biliary tract disease in cystic fibrosis. J Pediatr Gastroenterol Nutr S1 (1999) 1-13
2. Colombo C., Battezati P.M., Crosignani A., et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors and outcome. Hepatology 36 (2003) 1374-1382
3. Scott-Jupp R., Lama M., and Tanner M.S. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 66 (1991) 698-701
4. Nousia Arvanitakis S., Fotoloulaki M., Economou H., et al. Long term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis related liver disease. J Clin Gastroenterol 32 (2001) 324-328
5. Feigelson J., Anagnostopoulos C., Poquet M., et al. Liver cirrhosis in cystic fibrosis-therapeutic implications and long term follow up. Arch Dis Child 68 (1993) 653-657
6. Mc Kiernan P.J. Treatment of variceal bleeding. Gastrointest Endosc Clin N Am 11 (2001) 789-812
7. Rössle M., Haag K., Ochs A., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330 (1994) 165-171
8. Rössle M., and Grandt D. TIPSS: an update. Best Pract Res Clin Gastroenterol 18 (2004) 99-123
9. Uchiyama M., Iwafuchi M., Ohsawa Y., et al. Long-term results after nonshunt operations for esophageal varices in children. J Pediatr Surg 29 (1994) 1429-1433
10. Shun A., Delaney D.P., Martin H.C., et al. Portosystemic shunting for paediatric portal hypertension. J Pediatr Surg 32 (1997) 489-493
11. Orozco H., Mercado M.A., Martinez R., et al. Is splenectomy necessary in devascularisation procedures for treatment of bleeding portal hypertension?. Arch Surg 133 (1998) 36-38
12. Israel D.M., Hassall E., Cullham J.A.G., et al. Partial splenic embolisation in children with hypersplenism. J Pediatr 124 (1994) 95-100
13. Thalhammer G.H., Eber E., Uranüs S., et al. Partial splenectomy in cystic fibrosis patients with hypersplenism. Arch Dis Child 88 (2003) 143-146
14. Louis D., and Chazalette J.P. L'hypertension portale dans la mucoviscidose intérêt de la splénectomie partielle. Pathol Biol 39 (1991) 629-630
15. Wiliams S.G., Evanson J.E., Barrett N., et al. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol 22 (1995) 513-521
16. Waghorn D.J., and Mayon-White R.T. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?. J Infect 35 (1997) 289-294
17. Brigden M.L., Patullo A., and Brown G. Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 65 (2000) 25-29
18. Davidson R.N., and Wall R.A. Prevention and management of infections in patients without a spleen. Clin Micrbiol Infect 7 (2001) 657-660
19. Efrati O., Barak A., Modan-Moses D., et al. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur J Gastroenterol Hepatol 15 (2003) 1073-1078
20. Diwakar V., Pearson L., and Beath S. Liver disease in children with cystic fibrosis. Pediatr Respir Rev 2 (2001) 340-349
21. Fridel J.A., Bond G.V., Mazariegos G.V., et al. Liver transplantation in children with cystic fibrosis: a long term longitudinal review of a single center's experience. J Pediatr Surg 38 (2003) 1152-1156
22. Debray D., Lykavierris P., Gauthier F., et al. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 31 (1999) 77-83
23. Colombo C., Costantini D., Rocchi A., et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transplant Int 18 (2005) 246-255
24. Pozler O., Krajina A., Vanicek H., et al. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long term results. Hepatogastroenterology 50 (2003) 1111-1114
25. Wolff M., and Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg 388 (2003) 141-149
26. Chazalette J.P., Feigelson J., and Louis D. Partial splenectomy-worth the risk. Arch Dis Child 88 (2003) 649
27. Tanner J.M. Growth and adolescence. 2nd ed (1962), Blackwell scientific publications, Oxford